Susquehanna International Group
TARS icon

Susquehanna International Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Susquehanna International Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$337K Sell
4,800
-3,400
-41% -$238K ﹤0.01% 10620
2025
Q4 		$671K Sell
8,200
-7,600
-48% -$567K ﹤0.01% 8122
2025
Q3 		$939K Buy
+15,800
New +$778K ﹤0.01% 7506
2025
Q1 		– Sell
-17,100
Closed -$947K – 13436
2024
Q4 		$947K Buy
+17,100
New +$777K ﹤0.01% 7102
2024
Q3 		– Sell
-246,500
Closed -$6.7M – 13022
2024
Q2 		$6.7M Buy
246,500
+229,100
+1,317% +$7.7M ﹤0.01% 2997
2024
Q1 		$632K Buy
17,400
+2,700
+18% +$79.4K ﹤0.01% 7949
2023
Q4 		$298K Sell
14,700
-1,500
-9% -$25K ﹤0.01% 9863
2023
Q3 		$288K Buy
+16,200
New +$287K ﹤0.01% 9437

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return